Mersana Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Mersana Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • Mersana Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $5.39M, a 36% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $5.39M -$3.03M -36% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $6.18M -$2.95M -32.3% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $6.95M -$2.86M -29.1% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $7.69M -$2.78M -26.5% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 $8.42M -$2.64M -23.9% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $9.13M -$2.56M -21.9% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $9.81M -$2.2M -18.3% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $10.5M -$2.41M -18.7% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $11.1M -$2.11M -16% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $11.7M -$2.05M -14.9% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $12M +$1.48M +14.1% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $12.9M +$1.95M +17.9% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $13.2M +$1.83M +16.1% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $13.7M +$2M +17.1% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $10.5M -$1.61M -13.3% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $10.9M +$8.34M +321% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $11.3M +$8.28M +271% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $11.7M +$8.23M +235% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 $12.1M +$8.19M +208% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $2.6M Dec 31, 2019 10-K 2021-02-26
Q3 2019 $3.06M Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $3.51M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $3.94M Mar 31, 2019 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.